Christina Lee

Hematologist/oncologist with a clinical and research focus in lymphoma

[ASCO @ASCO]

#ASCO23: SWOG-S1826 paves the way for nivolumab+AVD as new standard of care for advanced-stage Hodgkin lymphoma: https://t.co/fYaiId5Uuh #ASCODailyNews @cityofhope @DrLaCasce #lymsm

[NEJM @NEJM]

In the CARTITUDE-4 trial, patients with lenalidomide-refractory multiple myeloma who received ciltacabtagene autoleucel (cilta-cel) had significantly longer progression-free survival than those who received standard therapy. View full results: https://t.co/Wag2UTLm5f

#ASCO23

[NEJM @NEJM]

Late breaking at #ASCO23: In the phase 3 ZUMA-7 trial, patients with relapsed or refractory large B-cell lymphoma who received axi-cel (CD19-specific CAR T cells) had a 27.4% lower risk of death than patients who received standard therapy. Full trial results:

[Blood Journals Portfolio @BloodPortfolio]

How I treat older patients with DLBCL in the frontline setting https://t.co/wrlvOfZTeG

[Christina Lee @christinaleemd]

@MGBayerl_MD AITL?

[Michael Wang, MD @michaelwangmd]

Great meeting on CAR T cell therapies with lymphoma experts!
⁦@JulioChavezMD⁩ ⁦@christinaleemd⁩ ⁦@PeterRiedel7⁩ ⁦⁦⁦@UF_IFS⁩ ⁦@UncleToba⁩ ⁦@niravshah112⁩

[Stony Brook Department of Medicine @sbudeptofmed]

📣 Funded! Congratulations to PI Dr. @CharlesVorkas @StonyBrookID @StonyBrookMed on the @NIAIDNews @NIH grant award for the project “Identification of Mycobacterium #tuberculosis-derived metabolites acting as ligands for MR-1 restricted T cells.” #IDTwitter

[Christina Lee @christinaleemd]

@sbudeptofmed @StonyBrookMed @AmericanCancer @aicrtweets Very grateful for the support from @AmericanCancer and @StonyBrookMed to study the role of MAIT cells in lymphoma and other hematologic malignancies and their potential for new cancer immunotherapy—an exciting collaboration with @CharlesVorkas laboratory.

[Santosh Vardhana @SantoshVardhana]

I’m thrilled that the 3rd chapter of our explorations of #COVID19 in patients with cancer is out today in @Cancer_Cell! Thread (1/24):
https://t.co/DQUsic8RIo

[Charles Vorkas @CharlesVorkas]

The Vorkas Lab has an opening for a postdoctoral associate. Please see details attached and apply through online portal. #postdoc Stony Brook University @CharlesVorkas https://t.co/s3rjl7Lpcg

[Christina Lee @christinaleemd]

@SantoshVardhana @katenokv Wow congrats!!!

[Cancer Discovery @CD_AACR]

#OnlineFirst: Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies. https://t.co/5lwKKawyW8
@christinaleemd @SantoshVardhana @VardhanaLab @sloan_kettering #lymphoma #COVID19

[Elizabeth McKenna @ElizSMcKenna]

Now online in @CD_AACR: Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies @christinaleemd @SantoshVardhana @VardhanaLab @sloan_kettering #lymphoma #COVID19 https://t.co/bYEZk14cYG

[Christina Lee @christinaleemd]

@NicoleCruzMD @guildsman @nyulisom @NYULangoneLI @docbraunstein ditto! so proud of you…congrats!

[Blood Cancer Discovery @BCD_AACR]

Just published! Two @sloan_kettering studies on response to mRNA #COVID19 vaccines after 1 and 3 months in two large cohorts encompassing major disease and therapy types.

[Santosh Vardhana @SantoshVardhana]

I’m thrilled to share a pre-print from @christinaleemd and our lab, in collaboration with @bengrbm, @mini_kamboj, and @EBabady that fully characterizes persistent COVID-19 infection as a chronic syndrome distinct from “long COVID”. A short thread: 1/x https://t.co/CVKOavtm7W

[Christina Lee @christinaleemd]

@MSK_MedChiefs @sloan_kettering An amazing group, congratulations!!

[Stephan Grupp MD PhD @GruppSteve]

Emily Whitehead, #CARTcell pioneer and the first pediatric ALL CART19 patient, now 9 years out from her infusion followed by sustained CR initially documented 23 days later. Much of what we know about #CARTcell CRS management we learned from her. @CHOPCancerCntr #Tocilizumab

[Blood Journals Portfolio @BloodPortfolio]

T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis https://t.co/wHsUgfGCbL

[Carla Casulo, MD @DrCarlaCasulo]

Join ⁦@WomenInLymphoma⁩ ⁦@SoniSmithMD⁩ on our inaugural kick off WEEKLY educational series “WiLing Wednesdays”. First topic: Newly dxd #DLBCL. Register here, open to anyone!!
Zoom registration: tJ0qceGpqjosGNbTgGbRaw0wkOaAPV7YhYf8